Vaccine comprising endotoxoids or SAEP with LPS (BiosYnth)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVaccine comprising endotoxoids or SAEP with LPS (BiosYnth)
Drug Alias NameSAEP2-L2 antiparallelEndotoxoids/SAEP + LPS based vaccine
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionLipopolysaccharide (LPS) modulators
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiosynth
China Registration ClassN/A

Develop Information

Active CompaniesBiosynth
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A